Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer. | Genes Dis | 2023 | 37396515 | PubTator, text mining | PubMed |
| High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma. | Front Immunol | 2023 | 37388735 | PubTator, text mining | PubMed |
| Mutational pattern off homologous recombination repair (HRR)-related genes in upper tract urothelial carcinoma. | Cancer Med | 2023 | 37387466 | PubTator, text mining | PubMed |
| Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms. | Cell Biosci | 2023 | 37386520 | PubTator, text mining | PubMed |
| Biological insights in non-small cell lung cancer. | Cancer Biol Med | 2023 | 37381723 | PubTator, text mining | PubMed |
| Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma. | J Clin Med | 2023 | 37373581 | PubTator, text mining | PubMed |
| Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine. | Int J Mol Sci | 2023 | 37372997 | PubTator, text mining | PubMed |
| Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer. | Genes (Basel) | 2023 | 37372349 | PubTator, text mining | PubMed |
| Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. | Biomedicines | 2023 | 37371712 | PubTator, text mining | PubMed |
| Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy. | Cells | 2023 | 37371134 | PubTator, text mining | PubMed |
| Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression. | Cancers (Basel) | 2023 | 37370798 | PubTator, text mining | PubMed |
| B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours. | Cancers (Basel) | 2023 | 37370746 | PubTator, text mining | PubMed |
| Pluripotent stem cell-derived model of the post-implantation human embryo. | Nature | 2023 | 37369347 | PubTator, text mining | PubMed |
| Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer. | EMBO Rep | 2023 | 37366231 | PubTator, text mining | PubMed |
| PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation. | BMC Cancer | 2023 | 37349676 | PubTator, text mining | PubMed |
| Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics. | Biomater Res | 2023 | 37344853 | PubTator, text mining | PubMed |
| The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics. | Discov Oncol | 2023 | 37326784 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of PTRF in glioma via 1,022 samples. | BMC Cancer | 2023 | 37322408 | PubTator, text mining | PubMed |
| Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy. | Transl Cancer Res | 2023 | 37304539 | PubTator, text mining | PubMed |
| Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance. | Int J Mol Sci | 2023 | 37298230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=19